Findings

What do systematic reviews say?

13 questions · 13 findings · 1 reviews · Heart

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 3 · 23.1%Very low 6 · 46.2%Low 4 · 30.8%Moderate 0 · 0%High 0 · 0%

Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor

Health‐related quality of life · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 22 participants
Low

Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor

Performance status – functional class (NYHA) · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor

Functional capacityAssessed: 6MWT · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 155 participants
Low

Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor

MACE · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor

All‐cause mortality · DCM (non‐ischaemic)

It is very uncertain whether stem cell therapy (any type) changes all‐cause mortality compared with peripheral therapy with granulocyte colony‐stimulating factor (very low certainty).

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
RR 0.46 [0.16, 1.31]
3 studies · 195 participants
Very low

Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor

Procedural complications · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 60 participants
Very low

Stem cell therapy vs control

All‐cause mortality · DCM (non‐ischaemic)

It is very uncertain whether stem cell therapy changes all‐cause mortality compared with control (very low certainty).

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
RR 0.84 [0.54, 1.31]
7 studies · 361 participants
Very low

Stem cell therapy vs control

Procedural complications · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 361 participants
Very low

Stem cell therapy vs control

Health‐related quality of life · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 272 participants
Very low

Stem cell therapy vs control

Functional capacityAssessed: 6MWT · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 230 participants
Very low

Stem cell therapy vs control

Performance status – change in functional class (NYHA) · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 398 participants
Low

Stem cell therapy vs control

MACE · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Stem cell therapy vs control

Ventricular arrhythmias (within 30 days) · DCM (non‐ischaemic)

1 finding from 1 review

Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 504 participants
Low